MN Pharmaceuticals’ production standards, after the US approval, gets approval from UK also.
Production standards of MN Pharmaceuticals, leader company in Turkish pharmaceutical industry, gets approval from the British Ministry of Health, Medicines and Healthcare Products Regulatory Agency, in addition to approval from FDA.
August 4, 2008, Istanbul. MN Pharmaceuticals, leader establishment in Turkish pharmaceutical industry, continues to be appreciated by internationally respected authorities for its production standards. Production standards approved in 2007 by FDA (American Food and Drug Administration), the most meticulous establishment in the world in this field, have also been approved recently by the British Ministry of Health, Medicines and Healthcare Products Regulatory Agency and a Certificate of GMP Compliance of a Manufacturer has been issued.
In the certificate issued as a result of inspections conducted by the British Medicines and Healthcare Products Regulatory Agency in May 2008 in MN Pharmaceuticals’ modern plants where 1100 specialized workers produce raw materials and finished drugs, it was stated that MN Pharmaceuticals’ production standards were found to be in compliance with Good Manufacturing Practices in the scope of the valid 2003/94/EC Regulations.